Ann: Monepantel Anti-viral Activity Against SARS-CoV-2 Confirmed, page-54

Not over yet, good interview with RA ... from the UK. He is still highly confident in the scientific merits of MPL - but we do need to change things up - retain an outside GM on a performance based contract, transition RA to Chairman and deliver results on a timely basis:
1. Establish partnership with leading research based organization with motivation and political clout to fast track Covid-19 human Phase I/II
2. Crack the whip internally and get a meaningful batch of canine results to validate oncology results and secure one or more partnerships to address the animal and human markets.